相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling
Yufeng Xie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Direct in vivo evidence of CD4+ T cell requirement for CTL response and memory via pMHC-I targeting and CD40L signaling
Khawaja Ashfaque Ahmed et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
Y. Chen et al.
CANCER GENE THERAPY (2011)
GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4+ T-independent CTL responses
Roopa Hebbandi Nanjundappa et al.
VACCINE (2011)
HER-2/neu as a target for cancer vaccines
Constantin N. Baxevanis et al.
IMMUNOTHERAPY (2010)
Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice
Olga Radkevich-Brown et al.
CANCER RESEARCH (2009)
Cancer immunotherapy
Constantin N. Baxevanis et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
Asim Saha et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice
S. Sas et al.
CANCER GENE THERAPY (2008)
DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies
Paula J. Whittington et al.
CANCER RESEARCH (2008)
Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen
Rinke Bos et al.
CANCER RESEARCH (2008)
Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity
Maria de la Luz Garcia-Hernandez et al.
CANCER RESEARCH (2008)
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C. Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Nonspecific CD4+ T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8+ CTL responses and long-term T cell memory
Siguo Hao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Trastuzumab-resistant HER2-Driven breast cancer cells are sensitive to epigallocatechin-3 gallate
Sean F. Eddy et al.
CANCER RESEARCH (2007)
Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses
Siguo Hao et al.
JOURNAL OF IMMUNOLOGY (2007)
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen
Asim Saha et al.
CANCER RESEARCH (2007)
HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination
T. Chan et al.
GENE THERAPY (2006)
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2006)
Immunogenic HER-2/neu peptides as tumor vaccines
CN Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
HER2 therapy - Molecular mechanisms of trastuzumab resistance
Rita Nahta et al.
BREAST CANCER RESEARCH (2006)
More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells
SM Dai et al.
CLINICAL CANCER RESEARCH (2005)
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy
CN Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin
C Lane et al.
CANCER RESEARCH (2004)
The HER-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy
JS Ross et al.
ONCOLOGIST (2003)
Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor
Z Chen et al.
CANCER GENE THERAPY (2002)
Overexpression of HER2/neu in solid tumours: an immunohistochemical survey
HKW Koeppen et al.
HISTOPATHOLOGY (2001)
分享论文
